MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA region of mtDNA — unlike nuclear-encoded peptides, its very existence challenges traditional gene expression models. This unique origin makes MOTS-c a valuable tool for studying mitochondrial-nuclear communication in metabolic regulation.
🧬 MOTS-c Key Facts
| Property | Value |
|---|---|
| Sequence | MRWQEMGYIFYPRKLR |
| Molecular Weight | 2174.7 Da |
| Amino Acids | 16 |
| Origin | Mitochondrial 12S rRNA ORF |
| Primary Target | Folate cycle / AMPK pathway |
| Solubility | Water-soluble |
🔬 Mechanism of Action
MOTS-c translocates to the nucleus under metabolic stress and regulates nuclear gene expression — this nuclear translocation is the key mechanistic feature that distinguishes it from most other mitochondrial peptides. Specifically, MOTS-c inhibits the folate cycle at the level of 5-methyltetrahydrofolate and activates AMPK, creating downstream effects on glucose metabolism and fatty acid oxidation.
🧪 Experimental Design Considerations
- Solubility: MOTS-c is water-soluble — reconstitute in sterile water or PBS. No DMSO or organic solvents needed
- Stability: Lyophilized at -20°C is stable 12+ months. Reconstituted, use within 7 days at 2-8°C
- Purity standard: ≥98% by HPLC. The peptide’s nuclear effects are concentration-dependent; impurities may confound
- MS verification: 2174.7 Da by MALDI-TOF or ESI-MS. Deviations >2 Da suggest sequence errors or modifications
- Controls: Include a scrambled peptide control if studying MOTS-c’s sequence-specific effects
📊 Benchmarking MOTS-c in Research
MOTS-c research is still relatively early-stage compared to well-established peptides like GLP-1 agonists — published literature is growing rapidly but total study count is under 200 as of 2025. This makes it a frontier research area with significant discovery potential, but also means experimental protocols are less standardized than for more established peptides. Review recent literature carefully before designing experiments.
❓ FAQ
Q: Why is MOTS-c classified differently from most peptides?
A: MOTS-c is encoded in mitochondrial DNA, not nuclear DNA — it’s a “mitochondrial-derived peptide” (MDP), a class discovered only in the past decade. This makes it fundamentally different from peptides like Tirzepatide or BPC-157, which are synthetic or derived from nuclear-encoded proteins.
Q: What’s the recommended purity for MOTS-c in cell-based assays?
A: ≥98% by HPLC — mitochondrial peptides can contain mtDNA fragments from the expression system that interfere with cell-based readouts. MS confirmation of the correct mass (2174.7 Da) is equally important, as sequence errors in synthetic peptides are more common at short lengths.
Q: Are there known MOTS-c analogs or modifications?
A: Several research groups have published MOTS-c analogs with amino acid substitutions to study structure-activity relationships, but wild-type MOTS-c remains the primary research tool. If your experiment requires analog forms, verify the supplier provides sequence confirmation via MS/MS for the specific analog ordered.